26 results
8-K
EX-99.1
vm99qol
17 Feb 21
Hepion Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
8:06am
8-K
x5pvh3s1kqqw
10 Jun 20
Hepion Pharmaceuticals Welcomes Industry Veteran and Drug Development Expert, Dr. Peter Wijngaard, to its Board of Directors
5:04pm
10-KT
j7sjg30y9lneos1hipi
26 Mar 18
Annual report (with FYE transition)
12:00am
424B5
0f7b7z
7 Oct 15
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
f85rwoi
15 Jan 15
ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer
12:00am
DEF 14A
gn6mdhuhyhxu in
27 Oct 14
Definitive proxy
12:00am
PRER14A
vda9my6cyl2j
23 Oct 14
Preliminary revised proxy
12:00am
10-K
iim7or dx7dioza
29 Sep 14
Annual report
12:00am